New Brunswick, New Jersey-based Johnson & Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a ...

JNJ's 62-year streak of dividend growth, 3.4% yield, and disciplined capital allocation make it highly attractive for ...

In the latest trading session, Johnson & Johnson (JNJ) closed at $152.43, marking a -0.54% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.56%.

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, July 16th to review second-quarter results. Joaquin Duato, Chairman and Chief ...

Johnson & Johnson's recent earnings beat expectations, with strong Medicine and MedTech growth. Read why I have a buy rating ...

Johnson & Johnson is a dividend king stock whose strong product line and consistency has earned it a listing on the Dow Jones ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

Johnson & Johnson MedTech (NYSE: JNJ) today announced results from a study of its Monarch platform for robotic bronchoscopy ...

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds. Based ...

For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.